Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Neoplasms of the CNS

  Free Subscription

Articles published in Acta Neuropathol

Retrieve available abstracts of 57 articles:
HTML format
Text format

Single Articles

    March 2019
  1. ELLISON DW, Hawkins C, Jones DTW, Onar-Thomas A, et al
    cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAF(V600E) mutation.
    Acta Neuropathol. 2019 Mar 8. pii: 10.1007/s00401-019-01987.
    PubMed     Text format    

  2. BLANLUET M, Masliah-Planchon J, Giurgea I, Bielle F, et al
    SHH medulloblastoma in a young adult with a TCF4 germline pathogenic variation.
    Acta Neuropathol. 2019 Mar 8. pii: 10.1007/s00401-019-01983.
    PubMed     Text format    

  3. HELLWIG M, Lauffer MC, Bockmayr M, Spohn M, et al
    TCF4 (E2-2) harbors tumor suppressive functions in SHH medulloblastoma.
    Acta Neuropathol. 2019 Mar 4. pii: 10.1007/s00401-019-01982.
    PubMed     Text format     Abstract available

  4. KORSHUNOV A, Sahm F, Okonechnikov K, Ryzhova M, et al
    Desmoplastic/nodular medulloblastomas (DNMB) and medulloblastomas with extensive nodularity (MBEN) disclose similar epigenetic signatures but different transcriptional profiles.
    Acta Neuropathol. 2019 Mar 2. pii: 10.1007/s00401-019-01981.
    PubMed     Text format     Abstract available

    February 2019
  5. SILVEIRA AB, Kasper LH, Fan Y, Jin H, et al
    H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo.
    Acta Neuropathol. 2019 Feb 15. pii: 10.1007/s00401-019-01975.
    PubMed     Text format     Abstract available

    October 2018
  6. SIEVERS P, Stichel D, Hielscher T, Schrimpf D, et al
    Chordoid meningiomas can be sub-stratified into prognostically distinct DNA methylation classes and are enriched for heterozygous deletions of chromosomal arm 2p.
    Acta Neuropathol. 2018 Oct 31. pii: 10.1007/s00401-018-1924.
    PubMed     Text format    

    September 2018
  7. XU K, Ding L, Chang TC, Shao Y, et al
    Structure and evolution of double minutes in diagnosis and relapse brain tumors.
    Acta Neuropathol. 2018 Sep 28. pii: 10.1007/s00401-018-1912.
    PubMed     Text format     Abstract available

  8. BRAT DJ, Aldape K, Colman H, Holland EC, et al
    cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".
    Acta Neuropathol. 2018 Sep 26. pii: 10.1007/s00401-018-1913.
    PubMed     Text format    

  9. LOPEZ GY, Van Ziffle J, Onodera C, Grenert JP, et al
    The genetic landscape of gliomas arising after therapeutic radiation.
    Acta Neuropathol. 2018 Sep 8. pii: 10.1007/s00401-018-1906.
    PubMed     Text format     Abstract available

  10. STICHEL D, Ebrahimi A, Reuss D, Schrimpf D, et al
    Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma.
    Acta Neuropathol. 2018 Sep 5. pii: 10.1007/s00401-018-1905.
    PubMed     Text format     Abstract available

    August 2018
  11. VALERA ET, McConechy MK, Gayden T, Rivera B, et al
    Methylome analysis and whole-exome sequencing reveal that brain tumors associated with encephalocraniocutaneous lipomatosis are midline pilocytic astrocytomas.
    Acta Neuropathol. 2018 Aug 24. pii: 10.1007/s00401-018-1898.
    PubMed     Text format    

  12. JURATLI TA, McCabe D, Nayyar N, Williams EA, et al
    DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome.
    Acta Neuropathol. 2018 Aug 19. pii: 10.1007/s00401-018-1899.
    PubMed     Text format     Abstract available

  13. VON BUEREN AO, Karremann M, Gielen GH, Benesch M, et al
    Correction to: A suggestion to introduce the diagnosis of "diffuse midline glioma of the pons, H3 K27 wildtype (WHO grade IV)".
    Acta Neuropathol. 2018 Aug 16. pii: 10.1007/s00401-018-1896.
    PubMed     Text format     Abstract available

    June 2018
  14. YANG RR, Aibaidula A, Wang WW, Chan AK, et al
    Pediatric low-grade gliomas can be molecularly stratified for risk.
    Acta Neuropathol. 2018 Jun 14. pii: 10.1007/s00401-018-1874.
    PubMed     Text format     Abstract available

    May 2018
  15. VON BUEREN AO, Karremann M, Gielen GH, Benesch M, et al
    A suggestion to introduce the diagnosis of "diffuse midline glioma of the pons, H3 K27 wildtype (WHO grade IV)".
    Acta Neuropathol. 2018 May 21. pii: 10.1007/s00401-018-1863.
    PubMed     Text format    

  16. LESKE H, Rushing E, Budka H, Niehusmann P, et al
    K27/G34 versus K28/G35 in histone H3-mutant gliomas: A note of caution.
    Acta Neuropathol. 2018 May 15. pii: 10.1007/s00401-018-1867.
    PubMed     Text format    

    April 2018
  17. SHIRAHATA M, Ono T, Stichel D, Schrimpf D, et al
    Novel, improved grading system(s) for IDH-mutant astrocytic gliomas.
    Acta Neuropathol. 2018 Apr 23. pii: 10.1007/s00401-018-1849.
    PubMed     Text format     Abstract available

  18. PHI JH, Park AK, Lee S, Choi SA, et al
    Genomic analysis reveals secondary glioblastoma after radiotherapy in a subset of recurrent medulloblastomas.
    Acta Neuropathol. 2018 Apr 11. pii: 10.1007/s00401-018-1845.
    PubMed     Text format     Abstract available

  19. KATZ LM, Hielscher T, Liechty B, Silverman J, et al
    Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence.
    Acta Neuropathol. 2018 Apr 7. pii: 10.1007/s00401-018-1844.
    PubMed     Text format     Abstract available

  20. BARTHEL FP, Wesseling P, Verhaak RGW
    Reconstructing the molecular life history of gliomas.
    Acta Neuropathol. 2018 Apr 3. pii: 10.1007/s00401-018-1842.
    PubMed     Text format     Abstract available

    March 2018
  21. KORSHUNOV A, Sahm F, Stichel D, Schrimpf D, et al
    Molecular characterization of medulloblastomas with extensive nodularity (MBEN).
    Acta Neuropathol. 2018 Mar 22. pii: 10.1007/s00401-018-1840.
    PubMed     Text format     Abstract available

  22. REINHARDT A, Stichel D, Schrimpf D, Sahm F, et al
    Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.
    Acta Neuropathol. 2018 Mar 21. pii: 10.1007/s00401-018-1837.
    PubMed     Text format     Abstract available

  23. NEIDERT MC, Kowalewski DJ, Silginer M, Kapolou K, et al
    The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy.
    Acta Neuropathol. 2018 Mar 20. pii: 10.1007/s00401-018-1836.
    PubMed     Text format     Abstract available

  24. APPS JR, Carreno G, Gonzalez-Meljem JM, Haston S, et al
    Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target.
    Acta Neuropathol. 2018 Mar 14. pii: 10.1007/s00401-018-1830.
    PubMed     Text format     Abstract available

  25. LOUIS DN, Giannini C, Capper D, Paulus W, et al
    cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant.
    Acta Neuropathol. 2018 Mar 1. pii: 10.1007/s00401-018-1826.
    PubMed     Text format    

    February 2018
  26. LABRECHE K, Kinnersley B, Berzero G, Di Stefano AL, et al
    Diffuse gliomas classified by 1p/19q co-deletion, TERT promoter and IDH mutation status are associated with specific genetic risk loci.
    Acta Neuropathol. 2018 Feb 19. pii: 10.1007/s00401-018-1825.
    PubMed     Text format     Abstract available

  27. IORGULESCU JB, Van Ziffle J, Stevers M, Grenert JP, et al
    Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activation.
    Acta Neuropathol. 2018 Feb 12. pii: 10.1007/s00401-018-1819.
    PubMed     Text format    

  28. GLOWACKA WK, Jain H, Okura M, Maimaitiming A, et al
    5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma.
    Acta Neuropathol. 2018 Feb 10. pii: 10.1007/s00401-018-1821.
    PubMed     Text format     Abstract available

    January 2018
  29. BADY P, Kurscheid S, Delorenzi M, Gorlia T, et al
    The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033.
    Acta Neuropathol. 2018 Jan 24. pii: 10.1007/s00401-018-1810.
    PubMed     Text format     Abstract available

  30. MUSTAFA DAM, Pedrosa RMSM, Smid M, van der Weiden M, et al
    T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression.
    Acta Neuropathol. 2018 Jan 19. pii: 10.1007/s00401-018-1806.
    PubMed     Text format     Abstract available

  31. PRATT D, Natarajan SK, Banda A, Giannini C, et al
    Circumscribed/non-diffuse histology confers a better prognosis in H3K27M-mutant gliomas.
    Acta Neuropathol. 2018 Jan 4. pii: 10.1007/s00401-018-1805.
    PubMed     Text format    

    November 2017
  32. BOGEAS A, Morvan-Dubois G, El-Habr EA, Lejeune FX, et al
    Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness.
    Acta Neuropathol. 2017 Nov 17. doi: 10.1007/s00401-017-1783.
    PubMed     Text format     Abstract available

  33. HASSELBLATT M, Johann PD, Kool M, Fruhwald MC, et al
    Reduced histone H3 K27 trimethylation is encountered in about 50% of atypical teratoid/rhabdoid tumors (AT/RT) but is not associated with molecular subgroup status and outcome.
    Acta Neuropathol. 2017;134:817-818.
    PubMed     Text format    

  34. PANWALKAR P, Clark J, Ramaswamy V, Hawes D, et al
    Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome.
    Acta Neuropathol. 2017;134:705-714.
    PubMed     Text format     Abstract available

    October 2017
  35. LOPEZ GY, Oberheim Bush NA, Phillips JJ, Bouffard JP, et al
    Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expression.
    Acta Neuropathol. 2017 Oct 23. doi: 10.1007/s00401-017-1780.
    PubMed     Text format    

  36. WIJNENGA MMJ, Dubbink HJ, French PJ, Synhaeve NE, et al
    Molecular and clinical heterogeneity of adult diffuse low-grade IDH wild-type gliomas: assessment of TERT promoter mutation and chromosome 7 and 10 copy number status allows superior prognostic stratification.
    Acta Neuropathol. 2017 Oct 19. doi: 10.1007/s00401-017-1781.
    PubMed     Text format    

  37. BEYER U, Brand F, Martens H, Weder J, et al
    Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesis.
    Acta Neuropathol. 2017 Oct 13. doi: 10.1007/s00401-017-1774.
    PubMed     Text format     Abstract available

  38. KORSHUNOV A, Chavez L, Northcott PA, Sharma T, et al
    DNA-methylation profiling discloses significant advantages over NanoString method for molecular classification of medulloblastoma.
    Acta Neuropathol. 2017 Oct 13. doi: 10.1007/s00401-017-1776.
    PubMed     Text format    

    August 2017
  39. NOMURA M, Mukasa A, Nagae G, Yamamoto S, et al
    Distinct molecular profile of diffuse cerebellar gliomas.
    Acta Neuropathol. 2017 Aug 29. doi: 10.1007/s00401-017-1771.
    PubMed     Text format     Abstract available

  40. D'ARONCO L, Rouleau C, Gayden T, Crevier L, et al
    Brainstem angiocentric gliomas with MYB-QKI rearrangements.
    Acta Neuropathol. 2017 Aug 12. doi: 10.1007/s00401-017-1763.
    PubMed     Text format    

  41. LOUIS DN, von Deimling A
    Grading of diffuse astrocytic gliomas: Broders, Kernohan, Zulch, the WHO... and Shakespeare.
    Acta Neuropathol. 2017 Aug 11. doi: 10.1007/s00401-017-1765.
    PubMed     Text format    

  42. CHAN E, Bollen AW, Sirohi D, Van Ziffle J, et al
    Angiocentric glioma with MYB-QKI fusion located in the brainstem, rather than cerebral cortex.
    Acta Neuropathol. 2017 Aug 3. doi: 10.1007/s00401-017-1759.
    PubMed     Text format    

  43. SINGH M, Venugopal C, Tokar T, Brown KR, et al
    RNAi screen identifies essential regulators of human brain metastasis-initiating cells.
    Acta Neuropathol. 2017 Aug 1. doi: 10.1007/s00401-017-1757.
    PubMed     Text format     Abstract available

    July 2017
  44. NEUMANN JE, Swartling FJ, Schuller U
    Medulloblastoma: experimental models and reality.
    Acta Neuropathol. 2017 Jul 19. doi: 10.1007/s00401-017-1753.
    PubMed     Text format     Abstract available

    June 2017
  45. EUSKIRCHEN P, Bielle F, Labreche K, Kloosterman WP, et al
    Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing.
    Acta Neuropathol. 2017 Jun 21. doi: 10.1007/s00401-017-1743.
    PubMed     Text format     Abstract available

    May 2017
  46. SAHM F, Toprak UH, Hubschmann D, Kleinheinz K, et al
    Meningiomas induced by low-dose radiation carry structural variants of NF2 and a distinct mutational signature.
    Acta Neuropathol. 2017 May 4. doi: 10.1007/s00401-017-1715.
    PubMed     Text format    

    April 2017
  47. KORSHUNOV A, Schrimpf D, Ryzhova M, Sturm D, et al
    H3-/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic drivers.
    Acta Neuropathol. 2017 Apr 11. doi: 10.1007/s00401-017-1710.
    PubMed     Text format     Abstract available

  48. PUSCH S, Krausert S, Fischer V, Balss J, et al
    Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo.
    Acta Neuropathol. 2017;133:629-644.
    PubMed     Text format     Abstract available

    March 2017
  49. RAPP C, Warta R, Stamova S, Nowrouzi A, et al
    Identification of T cell target antigens in glioblastoma stem-like cells using an integrated proteomics-based approach in patient specimens.
    Acta Neuropathol. 2017 Mar 22. doi: 10.1007/s00401-017-1702.
    PubMed     Text format     Abstract available

  50. PEKMEZCI M, Rice T, Molinaro AM, Walsh KM, et al
    Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT.
    Acta Neuropathol. 2017 Mar 2. doi: 10.1007/s00401-017-1690.
    PubMed     Text format     Abstract available

  51. FUKUSHIMA S, Yamashita S, Kobayashi H, Takami H, et al
    Genome-wide methylation profiles in primary intracranial germ cell tumors indicate a primordial germ cell origin for germinomas.
    Acta Neuropathol. 2017;133:445-462.
    PubMed     Text format     Abstract available

  52. HUSE JT, Snuderl M, Jones DT, Brathwaite CD, et al
    Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway.
    Acta Neuropathol. 2017;133:417-429.
    PubMed     Text format     Abstract available

    January 2017
  53. OLAR A, Wani KM, Wilson CD, Zadeh G, et al
    Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma.
    Acta Neuropathol. 2017 Jan 27. doi: 10.1007/s00401-017-1678.
    PubMed     Text format     Abstract available

  54. LENTING K, Verhaak R, Ter Laan M, Wesseling P, et al
    Glioma: experimental models and reality.
    Acta Neuropathol. 2017 Jan 10. doi: 10.1007/s00401-017-1671.
    PubMed     Text format     Abstract available

  55. PAJTLER KW, Mack SC, Ramaswamy V, Smith CA, et al
    The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants.
    Acta Neuropathol. 2017;133:5-12.
    PubMed     Text format     Abstract available

  56. LOUIS DN, Aldape K, Brat DJ, Capper D, et al
    Announcing cIMPACT-NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy.
    Acta Neuropathol. 2017;133:1-3.
    PubMed     Text format    

    December 2016
  57. EL-HABR EA, Dubois LG, Burel-Vandenbos F, Bogeas A, et al
    A driver role for GABA metabolism in controlling stem and proliferative cell state through GHB production in glioma.
    Acta Neuropathol. 2016 Dec 28. doi: 10.1007/s00401-016-1659.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.